<!DOCTYPE html>
<html manifest="manifest.manifest">
<head>
	<meta http-equiv=Content-Type content="text/html; charset=utf-8">
	<title>MRCG Clinical Guidelines</title>
	<meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=2.0, user-scalable=1">
	<meta name=Generator content="Microsoft Word 14 (filtered)">
	<link rel="manifest" href="/manifest.json">	
<link rel="stylesheet" href="jquery.mobile-1.4.5.min.css" />
	<link rel="stylesheet" href="mystyle.css" />
	<script src="jquery-1.11.1.min.js"></script>
	<script src="jquery.mobile-1.4.5.min.js"></script>
	<script type="text/javascript" src="cordova.js"></script>
	<script>
	    		$(function(){
			$("[data-role='header'], [data-role='footer']").toolbar();
		});
  	  $(document).one('pagebeforecreate', function () {
	        $('input[data-type="search"]').val("");
	    	        $.get("panel.html", function (data2) {
            $.mobile.pageContainer.prepend(data2);
              $("[data-role=panel]").panel().enhanceWithin();
        }, "html");
	           $.get("header.html", function (data) {
      $.mobile.pageContainer.prepend(data);
      $("[data-role='header']").toolbar().enhanceWithin();
    }, "html");
    $.get("footer.html", function (data) {
      $.mobile.pageContainer.append(data);
      $("[data-role='footer']").toolbar().enhanceWithin();
    }, "html");
        $('.WordSection1').wrap('<div role="main" class="ui-content">');
        $('table').wrap('<div class="tableCont"></div>');
        $('img').wrap('<div class="tableCont"></div>');
        $.mobile.pageContainer.enhanceWithin();
	  });
	        $(document).bind( "pagechange", function( ) {
        $('table').wrap('<div class="tableCont"></div>');
        $('img').wrap('<div class="tableCont"></div>');
        $('.tableCont').enhanceWithin();
      } );
			// When the user scrolls down 20px from the top of the document, show the button
		window.onscroll = function() {scrollFunction()};
		function scrollFunction() {
		  if (document.body.scrollTop > 20 || document.documentElement.scrollTop > 20) {
			document.getElementById("myBtn").style.display = "block";
		  } else {
			document.getElementById("myBtn").style.display = "none";
		  }
		}
		// When the user clicks on the button, scroll to the top of the document
		function topFunction() {
		  document.body.scrollTop = 0; // For Safari
		  document.documentElement.scrollTop = 0; // For Chrome, Firefox, IE and Opera
		}</script>      
	

  

</head>

<body lang=EN-GB link=blue vlink=purple>

<div class=WordSection1>

<h1>Sickle cell disorders</h1>

<h2><i>Executive summary</i></h2>

<h2>Introduction</h2>

<p class=MsoNormal>Haemoglobin (Hb) is a tetrameric protein composed of four
subunits. In the foetus, the predominant Hb is HbF (which has 2 alpha and 2
gamma subunits). This is replaced in the postnatal period by HbA (which has 2
alpha and 2 beta subunits) and HbA2 (2 alpha and 2 delta subunits).</p>

<p class=MsoNormal>In sickle cell disease, an individual inherits 2 abnormal beta
subunits, at least one of which is HbS. This produces red blood cells which are
prone to sickling and cause a range of symptoms and pathology. </p>

<p class=MsoNormal>The common sickle cell syndromes are: HbSS disease, HbSC
disease, HbS-beta thalassaemia and other rare variants. The inheritance of SS
disease follows simple Mendelian principles.</p>

<h2>Target users</h2>

<p class=MsoListParagraphCxSpFirst style='margin-left:39.0pt;text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Doctors</p>

<p class=MsoListParagraphCxSpLast style='margin-left:39.0pt;text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Nurses</p>

<h2>Target area of use </h2>

<p class=MsoListParagraphCxSpFirst style='margin-left:39.0pt;text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Ward</p>

<p class=MsoListParagraphCxSpLast style='margin-left:39.0pt;text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Outpatient department</p>

<h2>Key areas of focus / New additions / Changes </h2>

<p class=MsoNormal>This guideline outlines the initial diagnosis and management
of sickle cell disease and its complications. </p>

<h2>Limitations</h2>

<p class=MsoNormal>Exchange transfusion and modern preventative treatments such
as hydroxyurea are not available in the Gambia. </p>

<span style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br clear=all
style='page-break-before:always'>
</span>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
style='font-size:12.0pt'>&nbsp;</span></b></p>

<h2>Presenting symptoms and signs</h2>

<p class=MsoNormal>The most common signs and symptoms are linked to anaemia. As
a result, they may feel tired or weak. Fatigue is one of the most common
symptoms of sickle cell anaemia.</p>

<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Non-specific symptoms:</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:54.0pt;text-indent:-18.0pt'><span
style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span>Fatigue </p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:54.0pt;text-indent:-18.0pt'><span
style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span>Headaches</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:54.0pt;text-indent:-18.0pt'><span
style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span>Dizziness</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:54.0pt;text-indent:-18.0pt'><span
style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span>Fever</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Pain in any part of the body</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Symptoms of specific syndromes:</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:54.0pt;text-indent:-18.0pt'><span
style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span>Shortness of breath</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:54.0pt;text-indent:-18.0pt'><span
style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span>Cough</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:54.0pt;text-indent:-18.0pt'><span
style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span>Abdominal distension</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:54.0pt;text-indent:-18.0pt'><span
style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span>Swelling of the hands or feet</p>

<p class=MsoListParagraphCxSpLast style='margin-left:54.0pt;text-indent:-18.0pt'><span
style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span>Leg ulcers</p>

<h2>Examination findings</h2>

<p class=MsoNormal>The early signs include: pallor, jaundice,
hepato-splenomegaly (signs of visceral sequestration) and hand-foot syndrome
(dactylitis).</p>

<p class=MsoNormal>Signs consistent with important complications include:</p>

<p class=MsoListParagraphCxSpFirst style='margin-left:36.15pt;text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Tachycardia, tachypnoea and hypotension (signs of sepsis)</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:36.15pt;text-indent:
-18.0pt'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Signs of heart failure and murmur due to anaemia</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:36.15pt;text-indent:
-18.0pt'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Respiratory distress (acute chest syndrome)</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:36.15pt;text-indent:
-18.0pt'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Bone pain consistent with vaso-occlusive crisis or osteomyelitis</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:36.15pt;text-indent:
-18.0pt'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Priapism</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:36.15pt;text-indent:
-18.0pt'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Haematuria</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:36.15pt;text-indent:
-18.0pt'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Evidence of stroke</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Leg ulcers</p>

<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Frontal bossing and protrusion of upper teeth (gnathopathy)</p>

<h2>Differential diagnoses</h2>

<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Rheumatic fever</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Rheumatoid arthritis</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Osteomyelitis</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Leukaemia</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Splenic abscess</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Hepatitis</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Ischaemic colitis</p>

<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Peptic ulcer.</p>

<span style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br clear=all
style='page-break-before:always'>
</span>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
style='font-size:12.0pt'>&nbsp;</span></b></p>

<h2>Investigations</h2>

<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Blood Tests:</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;text-indent:-18.0pt'><span
style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span>Hb genotype (sickle test has very low specificity and sensitivity
and is not useful)</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;text-indent:-18.0pt'><span
style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span>FBC &amp; reticulocytes( <span lang=EN-US>Reduced Hb, elevated
WCC, elevated Platelets, increased retics)</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;text-indent:-18.0pt'><span
style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span>Group and save</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Blood film or RDT for malaria parasites (<span lang=EN-US>sickled
cells, poikilocytes and target cells)</span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Microbiological screen: Urine dipstick
&amp; culture, blood culture   </span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Radiology: </span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;text-indent:-18.0pt'><span
style='font-family:"Courier New";color:black'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span style='color:black'>Chest x-ray if indicated (i.e.
symptoms/signs)</span></p>

<p class=MsoListParagraphCxSpLast style='margin-left:72.0pt;text-indent:-18.0pt'><span
style='font-family:"Courier New";color:black'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span style='color:black'>X-ray of the hands: </span><span
lang=EN-US>initially not informative but later shows evidence of</span><span
lang=EN-US style='color:black'> </span><span lang=EN-US>destruction and repair
of bones</span></p>

<h2>Management in OPD</h2>

<h3>Antibiotics: </h3>

<p class=MsoNormal>Patients who have previously been admitted to hospital with
a serious infection should be treated with prophylactic penicillin V 7.5 mg/kg
up to 500 mg BD. </p>

<h3>Folic acid:</h3>

<p class=MsoNormal>From 1 month to 3 years of age, give 2.5 mg OD. Above 3
years of age give, 5 mg OD. </p>

<h3>Anti-malarials:</h3>

<p class=MsoNormal>Patients should receive anti-malarial prophylaxis during the
transmission season. This should usually be started as soon as the first rain
has occurred (and not before) and should continue until the end of the calendar
year. Give mefloquine (5-10 mg/kg up to 250 mg once per week).</p>

<h3>Appointments</h3>

<p class=MsoNormal>Children with sickle cell disease are seen 3 monthly until 2
years of age and six-monthly thereafter, unless there are medical, educational
or psychosocial concerns in which case they should be seen more frequently. If
patients are stable, in Fajara, they should be referred on to another health
facility for ongoing care.</p>

<p class=MsoNormal>Children who have frequent crises have been shown to have
better outcomes if their parents bring them for medical care sooner when they
deteriorate. Teach carers about the importance of taking pain and fevers
seriously. Studies have shown that parents can be taught to recognize
splenomegaly, which is an indication to present to the clinic.</p>

<h2>Management on the ward</h2>

<p class=MsoNormal>Management is supportive unless there are complications or indications
for exchange transfusion. (This is not routinely offered and must be discussed
with a consultant.)</p>

<p class=MsoNormal><span style='color:black'>General management includes: </span></p>

<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Reassurance that the patient’s pain
will be relieved as soon as possible </span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Massage and distraction techniques may
help some children </span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Warmth</span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Establishing a position of maximum
comfort </span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Hyperhydration (see below)</span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Oxygen supplementation when necessary</span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Establish IV access as soon as possible
</span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Identification and treatment of
infection </span></p>

<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Regular observations and reassessment  </span></p>

<h3>Fluids (Sodium chloride 0.9%)</h3>

<p class=MsoNormal>Aim to give 1.5 times as much fluid as usual:</p>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=151 valign=top style='width:113.15pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span style='color:black'>Body weight (kg) </span></b></p>
  </td>
  <td width=424 valign=top style='width:318.35pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span style='color:black'>Fluids (mL/kg/day) </span></b></p>
  </td>
 </tr>
 <tr>
  <td width=151 valign=top style='width:113.15pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span style='color:black'>Up to 10 kg </span></p>
  </td>
  <td width=424 valign=top style='width:318.35pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span style='color:black'>150 mL/kg/day </span></p>
  </td>
 </tr>
 <tr>
  <td width=151 valign=top style='width:113.15pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span style='color:black'>11 - 20 kg </span></p>
  </td>
  <td width=424 valign=top style='width:318.35pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span style='color:black'>1500 mL + 75 mL/kg/day for each
  kilo over 10 kg </span></p>
  </td>
 </tr>
 <tr>
  <td width=151 valign=top style='width:113.15pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span style='color:black'>&gt;20 kg </span></p>
  </td>
  <td width=424 valign=top style='width:318.35pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span style='color:black'>2250 mL + 30 mL/kg/day for each
  1 kg body weight over 20kg </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span style='color:black'>&nbsp;</span></p>

<h3>Analgesia </h3>

<p class=MsoNormal>An analgesic ladder is used according to the severity of
pain and a pain tool must always be used to monitor effectiveness of pain
relief. </p>

<p class=MsoNormal>Give paracetamol (15 mg/kg up to 1 g QDS) or ibuprofen (5
mg/kg up to 400 mg TDS) as a single agent of pain relief if not already given. </p>

<p class=MsoNormal>If pain persists, give paracetamol and ibuprofen together.</p>

<p class=MsoNormal>If pain persists, continue paracetamol and ibuprofen and add:</p>

<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Codeine phosphate (0.5-1.0 mg/kg up to 30 mg TDS) for rapid oral
opiate pain relief.</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>If injectable pain relief required: SC Morphine (begin with
0.1-0.2 mg/kg up to 2.5 mg and titrate until pain is controlled).</p>

<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>If the patient requires regular on-going opiate pain relief, Morphine
Slow-release Tablets (MST) may be used in place of codeine phosphate. To find
the equivalent dose, divide total daily dose of codeine by 8-10 and give half
this amount as MST BD). </p>

<h2>Management of complications</h2>

<p class=MsoNormal><b><u>Veno-occlusive crisis:</u></b> Presents with bone or
body pain. Occurs when hypoxia, infection, dehydration or pregnancy trigger
sickling which causes capillary blockage. This results in local ischaemia of
tissues. In infants and toddlers, it often affects the hand and feet and
presents as dactylitis (which is a poor prognostic factor). If the spleen is
involved, it may suddenly enlarge and is very painful. This is also a poor
prognostic factor. Treatment is with pain relief and hyperhydration. If there
is evidence of infection, this should be treated. </p>

<p class=MsoNormal><b><u>Infection</u></b>: Occurs as a complication of a
veno-occlusive crisis or secondary to asplenism. Patients are at increased risk
of sepsis from capsulated bacteria including <i>pneumococcus</i>, <i>haemophilus
influenzae</i> and <i>salmonella</i> spp. Patients presenting with infections
severe enough to require hospital admission should be treated with the usual
antibiotics indicated for the suspected site of infection. The exception to
this is osteomyelitis, which should be treated with chloramphenicol 25 mg/kg up
to 500 mg QDS for 2 weeks.  Also, ensure child is fully vaccinated as this
helps with infection from some of the encapsulated bacteria listed above.</p>

<p class=MsoNormal><b><u>Stroke:</u></b> This is a complication of
veno-occlusive crisis affecting the brain. Ten percent (10%) of sickle cell
patients will have a stroke before the age of 20 years and those who have had
one stroke have a 60% chance of having a second stroke. Patients with an acute
stroke have a better outcome if they receive blood transfusion to keep their Hb
above 10 g/dl and oxygen to keep their saturations above 95%. They should then
continue to receive regular transfusions to keep their Hb at 10 g/dl. This
should ideally be done by exchange transfusion, but this is not available in
our setting. </p>

<p class=MsoNormal><b><u>Acute chest syndrome:</u></b> This is a complication
of veno-occlusive crisis affecting the lungs. This is commonly associated with
secondary respiratory infection. The mortality rate is 10% even in the best
centres. The patient should be treated with oxygen, salbutamol nebulisers and
benzyl penicillin 500,000 units/kg up to 2 megaunits QDS and chloramphenicol 25
mg/kg up to 500 mg QDS. Transfuse if the Hb is below 10 g/dl. </p>

<p class=MsoNormal><b><u>Renal failure:</u></b> will occur in one third of patients
over their lifetime. This is due to recurrent renal ischaemia. Patients with
sickle cell disease who are admitted must be adequately hydrated as above. </p>

<p class=MsoNormal><b><u>Complications of pregnancy:</u></b> occur when the placenta
becomes ischaemic during a crisis. This presents with spontaneous abortion,
placental abruption and premature labour. Pregnant sickle cell patients require
specialised obstetric care. Early referral to the O&amp;G unit of EFSTH is thus
necessary.</p>

<p class=MsoNormal><b><u>Priapism:</u></b> occurs when sickling affects the
penis and is very painful. It should be treated with adequate pain relief and
hyperhydration. If there is no rapid relief, blood must be aspirated from the
penis with a needle. Referral to the urologist is necessary at this point.</p>

<h2>Key Issues for Nursing care</h2>

<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Timely assessment of patients. </p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Advocate for rapid and effective treatment of pain. </p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Develop trusting relationship with patient and family. </p>

<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Educate patients to use a pro-active approach in pain management.
</p>

<h2>References</h2>

<p class=MsoNormal><span style='font-size:10.0pt'>Sickle Cell Information
Center (2016) What is sickle cell disease. Retrieved from
http://scinfo.org/index.php/what-is-sickle-cell-disease </span></p>

<p class=MsoNormal><span lang=EN-US><a href="http://www.sicklecelldisease.org/"><span
lang=EN-GB style='font-size:10.0pt;color:black'>http://www.sicklecelldisease.org/</span></a></span><span
style='font-size:10.0pt;color:black'>: </span></p>

<p class=MsoNormal><span lang=EN-US><a href="http://www.sicklecellsociety.org/"><span
lang=EN-GB style='font-size:10.0pt;color:black'>http://www.sicklecellsociety.org/</span></a></span><span
style='font-size:10.0pt;color:black'> : information, Counselling and Caring for
those with Sickle Cell Disorders and their families: UK based</span></p>

<p class=MsoNormal><span style='font-size:10.0pt'>Expert Panel Report, US
Department of Health and Human Services. Evidence-Based Management of Sickle
Cell Disease. <i>National Institutes of Health</i>. 2014. </span></p>

<p class=MsoNormal><span style='font-size:10.0pt'>Imperial Paediatric Sickle
Cell Pain Management Protocol</span></p>

<p class=MsoNormal><span style='font-size:10.0pt'>http://www.who.int/en/ </span></p>

<p class=MsoNormal><span style='font-size:10.0pt'>Nelson text book of
paediatrics</span></p>

<p class=MsoNormal><span style='font-size:10.0pt'>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b>Written
  by:</b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Name:
  Yorro Bah</p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Date: 22
  June 2019</p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b>Reviewed
  by:</b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Name: Karen
  Forrest</p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Date: 24
  July 2019</p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b>Version:</b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b>Change
  history:</b></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b>Review
  due date:</b></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>1.0</p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>New
  document</p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>30 August
  2021</p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Review
  Comments (<i>if applicable)</i></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>&nbsp;</p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b>&nbsp;</b></p>
  </td>
 </tr>
</table>

<p class=MsoNormal>&nbsp;</p>

</div>

</body>

</html>
